Physician profile
Robert D Williams
NPI 1003250689
$1,779.15
in general payments reported to CMS, 2019-2025
25 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.13 · 2021: $77.70 · 2022: $345 · 2023: $584 · 2024: $555 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $356.05 | 2023-2025 | Ams 700, Rezum Generator, Advantage System |
| Cook Medical LLC | $213.56 | 2021-2022 | |
| Teleflex LLC | $153.07 | 2022-2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $138.63 | 2023 | Pylarify |
| Pfizer INC. | $91.04 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $89.63 | 2023-2024 | Prolaris, Myrisk |
| Astellas Pharma US INC | $85.66 | 2023 | Xtandi |
| Blue Earth Diagnostics | $84.16 | 2023-2024 | |
| Procept Biorobotics Corporation | $76.27 | 2025 | |
| Abc Home Medical Supply, INC. | $64.71 | 2024 | |
| Olympus America INC. | $52.16 | 2022-2024 | Itind System |
| Tolmar, INC. | $49.61 | 2023-2024 | |
| Accord Healthcare, INC. | $38.91 | 2023 | |
| Novartis Pharmaceuticals Corporation | $37.66 | 2019-2024 | |
| Abbvie INC. | $37.02 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $32.83 | 2024 | |
| Medtronic, INC. | $31.67 | 2022-2023 | Interstim |
| Becton, Dickinson and Company | $23.79 | 2022 | |
| Urovant Sciences INC | $21.04 | 2022 | |
| Urogen Pharma, INC. | $19.82 | 2023 | Jelmyto |
| Innovation Technologies INC | $18.76 | 2024 | Irrisept |
| Tolmar Pharmaceuticals, INC. | $17.92 | 2022 | |
| Laborie Medical Technologies Corp. | $16.85 | 2023 | |
| Coloplast Corp | $14.31 | 2022 | |
| Verity Pharmaceuticals INC. | $14.02 | 2023 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.